Want to see NVO full AI Analyst Report?
Novo Nordisk (NVO) Income Statement
Novo Nordisk Income Statement
Last quarter (Q2 2026), Novo Nordisk's total revenue was $78.49B, an increase of 2.12% from the same quarter last year. In Q2, Novo Nordisk's net income was $20.99B. See Novo Nordisk’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 309.06B | $ 290.40B | $ 232.26B | $ 176.95B | $ 140.80B | |
| $ 250.28B | $ 245.88B | $ 196.50B | $ 148.51B | $ 117.14B | |
| $ 122.62B | $ 117.54B | $ 93.92B | $ 73.70B | $ 58.50B | |
| Depreciation and Amortization | $ 21.98B | $ 19.11B | $ 9.41B | $ 7.36B | $ 6.03B |
| $ 156.73B | $ 147.94B | $ 114.63B | $ 76.80B | $ 65.39B | |
| $ 127.66B | $ 128.34B | $ 102.57B | $ 74.81B | $ 58.64B | |
| $ 2.88B | $ -1.15B | $ 2.10B | $ -5.75B | $ 436.00M | |
| $ 130.54B | $ 127.19B | $ 104.67B | $ 69.06B | $ 59.08B | |
| $ 102.43B | $ 100.99B | $ 83.68B | $ 55.52B | $ 47.76B | |
| Per Share Metrics | |||||
| Basic EPS | $ 23.06 | $ 22.67 | $ 18.67 | $ 12.26 | $ 10.40 |
| Diluted EPS | $ 23.03 | $ 22.63 | $ 18.62 | $ 12.22 | $ 10.37 |
| Weighted Average Shares Outstanding | 4.45B | 4.45B | 4.48B | 4.53B | 4.59B |
| Weighted Average Shares Outstanding (Diluted) | 4.45B | 4.46B | 4.49B | 4.54B | 4.61B |
Currency in DKK